Clinical and Medical Case Reports

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain

Publications

• Case Report   
  Myopericarditis and pulmonary thrombosis after administration of the BNT162b2 vaccine against COVID-19 in a carrier of familial Mediterranean Fever
  Author(s): Elisabeth Gomez Moyano, German Alegre-García*, Isabel Piñeiro Uribe, Beatriz Pérez-Villardón, Javier Mora-Robles and Manuel Jiménez-Navarro
  
  Based on the current interest in the complications associated with vaccination against COVID-19, we present this case report of great interest that shows a carrier of familial Mediterranean fever who suffered myopericarditis and pulmonary thrombosis after administration of the BNT162b2 vaccine against COVID-19. Certain autoimmune disorders may be triggered by COVID-19 vaccination in genetically susceptible persons. A 40-year-old woman had a history of deep vein thrombosis in 2006 coinciding with taking oral contraceptives, and a daughter with familial Mediterranean fever. In January 2021, as part of the COVID-19 vaccination program, she received her first dose of the BNT162b2 vaccination. Thirteen hours after the second dose she presented at the hospital with oppressive chest pain and fever and after several tests, including a cardiac MRI, she was diagnosed.. Read More»
  DOI: 10.37421/2684-4915.2022.6.218

  Abstract HTML PDF